Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 3.18 EUR -0.16% Market Closed
Market Cap: 254.1m EUR

Wall Street
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 7.33 EUR with a low forecast of 4.04 EUR and a high forecast of 12.6 EUR.

Lowest
Price Target
4.04 EUR
27% Upside
Average
Price Target
7.33 EUR
130% Upside
Highest
Price Target
12.6 EUR
296% Upside
Oryzon Genomics SA Competitors:
Price Targets
6160
Beigene Ltd
36% Upside
TVTX
Travere Therapeutics Inc
5% Upside
SVRA
Savara Inc
64% Upside
VYGR
Voyager Therapeutics Inc
279% Upside
ADAG
Adagene Inc
409% Upside
AGIO
Agios Pharmaceuticals Inc
17% Upside
BBIO
BridgeBio Pharma Inc
12% Upside
PRTA
Prothena Corporation PLC
114% Upside

Revenue
Forecast

Revenue Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Net Income
Forecast

Net Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORY's stock price target?
Price Target
7.33 EUR

According to Wall Street analysts, the average 1-year price target for ORY is 7.33 EUR with a low forecast of 4.04 EUR and a high forecast of 12.6 EUR.

Back to Top